Arrowhead Pharmaceuticals
Clinical trials sponsored by Arrowhead Pharmaceuticals, explained in plain language.
-
New injection trial aims to tame deadly cholesterol in teens
Disease control Not yet recruitingThis study is testing an experimental injection called zodasiran in adolescents aged 12 to 18 who have a rare, severe genetic cholesterol disorder called homozygous familial hypercholesterolemia (HoFH). The main goal is to see if the injection safely lowers their 'bad' LDL choles…
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New inhaler aims to calm lungs after allergy attacks
Disease control Not yet recruitingThis study is testing a new inhaled medicine called ARO-RAGE to see if it can help control asthma symptoms triggered by allergies. It will involve 36 adults with mild, stable asthma who are allergic to common substances. Researchers will measure how well participants' small airwa…
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC